Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$688.78
+0.2%
$594.71
$437.37
$694.07
$211.52B1.322.38 million shs1.49 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.13
-0.5%
$23.42
$20.92
$31.54
$137.16B0.5741.21 million shs19.05 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$79.13
-1.0%
$73.58
$50.15
$81.50
$257.52B1.1617.26 million shs8.72 million shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
+2.76%+8.28%+11.81%+26.76%+50.90%
Pfizer Inc. stock logo
PFE
Pfizer
+0.06%+1.80%+2.94%-3.56%-11.36%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
+1.19%+7.06%+8.23%+13.17%+40.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.9045 of 5 stars
2.23.04.23.02.23.33.8
Pfizer Inc. stock logo
PFE
Pfizer
4.8684 of 5 stars
2.33.04.24.32.91.73.1
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
4.8045 of 5 stars
2.44.02.52.54.01.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.32
Hold$595.67-13.52% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.53
Moderate Buy$29.1720.90% Upside
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
2.75
Moderate Buy$77.98-1.45% Downside

Current Analyst Ratings Breakdown

Latest PFE, GS, and WFC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$570.00 ➝ $592.00
6/18/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy
6/18/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetStrong-Buy ➝ Strong-Buy$78.00 ➝ $84.00
6/10/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$76.00 ➝ $86.00
6/4/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$75.00 ➝ $85.00
6/4/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$72.00 ➝ $88.00
6/4/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$77.00 ➝ $87.00
6/4/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$83.00 ➝ $90.00
5/15/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$83.00
4/30/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $25.00
4/22/2025
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight ➝ Neutral$24.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$126.85B1.67$55.19 per share12.48$350.27 per share1.97
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.16$4.34 per share5.56$15.62 per share1.54
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$125.40B2.05$8.36 per share9.47$48.79 per share1.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$14.28B$43.0916.0013.230.9111.86%13.76%0.87%7/16/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3817.487.960.8812.62%20.33%8.53%8/5/2025 (Estimated)
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$19.72B$5.5714.2111.521.3216.19%12.15%1.03%7/15/2025 (Estimated)

Latest PFE, GS, and WFC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/16/2025Q2 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$9.82N/AN/AN/A$13.53 billionN/A
7/15/2025Q2 2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.41N/AN/AN/A$20.83 billionN/A
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/14/2025Q1 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.57$14.12+$1.55$14.12$14.99 billion$15.06 billion
4/11/2025Q1 2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.23$1.39+$0.16$1.39$20.82 billion$20.15 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.001.74%N/A27.85%13 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.13%N/A124.64%16 Years
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.602.02%N/A28.73%4 Years

Latest PFE, GS, and WFC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
4/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$3.002.3%5/30/20255/30/20256/27/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
4/29/2025
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
quarterly$0.402.28%5/9/20255/9/20256/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.41
0.68
0.68
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
1.06
0.84
0.84

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
75.90%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.08%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
46,500306.84 million305.15 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
217,0003.25 billion3.25 billionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$688.78 +1.62 (+0.24%)
As of 03:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$24.12 -0.12 (-0.47%)
As of 03:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Wells Fargo & Company stock logo

Wells Fargo & Company NYSE:WFC

$79.12 -0.84 (-1.04%)
As of 03:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.